In the realm of cancer care, the FCA can be applied to various fraudulent activities, such as billing for unnecessary medical procedures, inflating charges for chemotherapy drugs, or misrepresenting the effectiveness of a treatment. Such fraudulent activities can significantly impact the quality of care that cancer patients receive and the overall costs of cancer treatment.
